TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea

Clinical trial NCT02493530 · COMPLETED

Trial details

NCT number: NCT02493530
Sponsor: Vanderbilt-Ingram Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Myelofibrosis Polycythemia Vera

Start date: 2015-07-01
Primary completion: 2023-03-21
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.